EUVIMEDEUVIMED entdecken
Crossref

Inflammation, infarct size, and 10-year mortality in STEMI patients stratified by the ORBI Risk Score: a DANAMI-3 sub-study

Joakim Bo Kunkel iD, Jacob Lønborg iD, Martin Frydland iD, Burcu Tas Özbek iD, Lars Nepper-Christensen, Niels Vejlstrup iD, Kiril Ahtarovski, Lars Køber iD, Dan Eik Høfsten, Jasmine Melissa Marquard iD, Utsho Islam iD, Sarah Louise Duus Holle iD und 5 weitere

European Heart Journal: Acute Cardiovascular Care · 03.10.2026

DOI: 10.1093/ehjacc/zuag126 ↗

Kurz gefasst

Fachartikel in der Zeitschrift European Heart Journal: Acute Cardiovascular Care, online erschienen am 03.10.2026. Verfasst von Joakim Bo Kunkel und 16 weiteren Autor:innen. Beteiligte Einrichtung: Rigshospitalet - Copenhagen University Hospital, Department of Cardiology, Copenhagen, Denmark. Die Arbeit nennt 30 Literaturangaben. Gefördert von: Danish Agency for Science, Technology and Innovation, Danish Council for Strategic Research.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Aims

The ORBI Risk Score predicts in-hospital cardiogenic shock after primary percutaneous coronary intervention (PCI) for ST-elevation myocardial infarction (STEMI). Whether high-risk patients also have more systemic inflammation, larger infarcts, and higher long-term mortality is not known. Methods and results In a DANAMI-3 sub-study, 1574 STEMI patients without cardiogenic shock were classified as high (ORBI ≥8, n = 273) or low risk (n = 1301). Inflammation was assessed by routine C-reactive protein (CRP), leucocyte count, and neutrophil-to-lymphocyte ratio (NLR) within 72 h of PCI, and admission mid-regional pro-adrenomedullin (MR-proADM). Infarct size was measured by cardiac magnetic resonance. Ten-year all-cause mortality was obtained from the Danish Civil Registration System. Cox models were adjusted for age, sex, comorbidity, kidney function, and randomized allocation. High-risk patients had higher peak CRP (72 vs. 11 mg/L), leucocyte count (12.8 vs. 10.4 × 109/L), NLR (6.2 vs. 3.5), and MR-proADM (0.73 vs. 0.62 nmol/L; all P < 0.001), as well as larger infarcts (final infarct size 15.7% vs. 10.1% of left ventricular mass). Ten-year mortality was 41% vs. 20% [hazard ratio (HR) 2.56, 95% CI 2.05–3.20; adjusted 1.47, 1.16–1.85]. The adjusted HR was 4.79 within 30 days and 1.27 after the first year. The score discriminated 10-year mortality less well than age alone (area under the curve 0.67 vs. 0.79).

Conclusion

The ORBI Risk Score identifies STEMI patients with more inflammation, larger infarcts, and higher mortality, especially in the first year. Beyond the first year, the association was largely explained by age. Whether anti-inflammatory treatment benefits these patients is a question for randomized trials.

Schlagwörter

Stichwörter der Autor:innen

ORBI Risk ScoreST-segment elevation myocardial infarctionlong-term mortalitymyocardial infarct sizerisk stratificationsystemic inflammation

Autor:innen und Institutionen

  • Rigshospitalet - Copenhagen University Hospital, Department of Cardiology, Copenhagen, Denmark.
  • Zealand University Hospital, Department of Cardiology, Roskilde, Denmark.
  • University of Copenhagen, Department of Clinical Medicine, Copenhagen, Denmark.
  • Skånes University Hospital, Department of Cardiology, Lund, Sweden.

ORCID-Profile: Joakim Bo Kunkel, Jacob Lønborg, Martin Frydland, Burcu Tas Özbek, Niels Vejlstrup, Lars Køber, Jasmine Melissa Marquard, Utsho Islam, Sarah Louise Duus Holle, Yan Zhou, Lene Holmvang, Christian Hassager, Thomas Engstrøm, Helle Søholm

Förderung

  • Danish Agency for Science, Technology and Innovation
  • Danish Council for Strategic Research

Zitieren

APA

Kunkel, J. B., Lønborg, J., Frydland, M., Özbek, B. T., Nepper-Christensen, L., Vejlstrup, N., Ahtarovski, K., Køber, L., Høfsten, D. E., Marquard, J. M., Islam, U., Duus Holle, S. L., Zhou, Y., Holmvang, L., Hassager, C., Engstrøm, T., & Søholm, H. (2026). Inflammation, infarct size, and 10-year mortality in STEMI patients stratified by the ORBI Risk Score: a DANAMI-3 sub-study. European Heart Journal: Acute Cardiovascular Care. https://doi.org/10.1093/ehjacc/zuag126

Vancouver

Kunkel JB, Lønborg J, Frydland M, Özbek BT, Nepper-Christensen L, Vejlstrup N, et al. Inflammation, infarct size, and 10-year mortality in STEMI patients stratified by the ORBI Risk Score: a DANAMI-3 sub-study. European Heart Journal: Acute Cardiovascular Care. 2026. doi:10.1093/ehjacc/zuag126

BibTeX
@article{Kunkel2026,
  author = {Kunkel, Joakim Bo and Lønborg, Jacob and Frydland, Martin and Özbek, Burcu Tas and Nepper-Christensen, Lars and Vejlstrup, Niels and Ahtarovski, Kiril and Køber, Lars and Høfsten, Dan Eik and Marquard, Jasmine Melissa and Islam, Utsho and Duus Holle, Sarah Louise and Zhou, Yan and Holmvang, Lene and Hassager, Christian and Engstrøm, Thomas and Søholm, Helle},
  title = {Inflammation, infarct size, and 10-year mortality in STEMI patients stratified by the ORBI Risk Score: a DANAMI-3 sub-study},
  journal = {European Heart Journal: Acute Cardiovascular Care},
  year = {2026},
  doi = {10.1093/ehjacc/zuag126}
}
Kostenlos starten →